News Article

Candesic is delighted to have conducted operational due diligence for leading global alternative investment manager Ares Management prior to its strategic investment in Linimed Gruppe GmbH.

Linimed is a leading German provider of community intensive care services, and the financing will be used to support its continuing growth strategy.

The Candesic team was led by senior partner Marc Kitten and senior engagement manager Dr Chris Cassar.

European specialist healthcare investor GHO Capital, Linimed’s majority shareholder since 2018, has brought Ares in as a new financing partner alongside its existing lenders – BlackRock and Berenberg.

James Kim, partner at Ares, said: “We are pleased to provide flexible capital to support Linimed, a high-quality business operating a differentiated care model with a strong management team and a well-defined growth strategy in a compelling sector. Partnering alongside GHO, a specialist healthcare investor with deep sector expertise, enables us to back Linimed’s strategic ambitions.

“The ageing German population and the continued shift toward community-based care create durable, long-term demand, and Linimed is well positioned to meet it. We look forward to working closely with management and GHO in this exciting new chapter of organic and accretive inorganic growth.”

It has been a busy time for Linimed, which has just completed the acquisition of GeBomed GmbH. This is an ambulatory outpatient nursing service based in the Lower Rhine region, and marks Linimed’s twelfth add-on transaction since partnering with GHO. The group plans to leverage its operational expertise to broaden GeBomed’s service offering into intensive care.

Congratulations to everyone involved in making this deal a success.
We undertake extensive work across this sector and are always happy to discuss opportunities and market developments. Feel free to connect with us on LinkedIn or contact us at [email protected]